High Blood Calcium (Hypercalcemia): Causes, Symptoms, and Treatment
Hypercalcemia (serum calcium >10.5 mg/dL or ionized >5.6 mg/dL) is a common metabolic disorder with diverse etiologies. The two most frequent causes—primary hyperparathyroidism and malignancy—account for >90% of cases.
Etiologic Classification
1. PTH-Mediated
- Primary hyperparathyroidism (PHPT): Parathyroid adenoma (80–85%), hyperplasia (15%), carcinoma (<1%). High PTH, high Ca²⁺. Asymptomatic or "stones, bones, groans, moans."
- Familial Hypocalciuric Hypercalcemia (FHH): CASR inactivating mutation → low urine Ca²⁺ (CCCR <0.01), mild hypercalcemia, normal/mildly elevated PTH. Benign; no surgery.
- Lithium therapy: Shifts Ca²⁺ set-point → mild PHPT-like picture.
2. PTH-Independent (PTH Suppressed)
- Malignancy:
- Humoral: PTHrP secretion (squamous cell, breast, renal, ovarian) → 80% of malignancy hypercalcemia.
- Local osteolysis: Bone metastases (breast, prostate, myeloma) → RANKL-mediated osteoclast activation.
- Vitamin D-mediated: Lymphomas (1,25-(OH)₂D overproduction).
- Granulomatous diseases: Sarcoidosis, TB, fungal — macrophage 1α-hydroxylase → ↑1,25-(OH)₂D → ↑gut Ca²⁺ absorption.
- Endocrine: Thyrotoxicosis (bone turnover), Addison's (hemoconcentration + ↓renal excretion), acromegaly.
- Drugs: Thiazides (↓Ca²⁺ excretion), vitamin D/A excess, calcium supplements (milk-alkali syndrome), denosumab (rebound).
- Immobilization: Rapid bone resorption in high-turnover states (adolescents, Paget's).
3. Renal
- CKD: Usually hypocalcemia; tertiary HPT (autonomous PTH) → hypercalcemia post-transplant.
Clinical Presentation
Symptoms correlate with severity and acuity:
- Mild (<12 mg/dL): Often asymptomatic; fatigue, polyuria, constipation.
- Moderate (12–14 mg/dL): Nausea, vomiting, anorexia, confusion, polyuria/polydipsia (nephrogenic DI).
- Severe (>14 mg/dL): Altered mental status, coma, cardiac arrhythmias (shortened QT), acute kidney injury, pancreatitis.
Diagnostic Workup
- Albumin-corrected Ca²⁺ or ionized Ca²⁺ (confirm)
- Intact PTH (differentiates PTH-mediated vs. independent)
- PTHrP if PTH low + suspicion for malignancy
- 25-OH-D, 1,25-(OH)₂D, SPEP/UPEP, TSH, cortisol
- Imaging per suspicion (parathyroid sestamibi, CT chest/abdomen, bone survey)
Acute Management (Severe/Symptomatic)
- IV 0.9% saline 200–300 mL/hr → target urine >100 mL/hr
- Loop diuretic (furosemide) only after volume repletion
- Bisphosphonate (zoledronic acid 4 mg IV) or denosumab 120 mg SC — onset 24–48h
- Calcitonin 4 IU/kg q12h (rapid but tachyphylaxis in 48h)
- Dialysis if renal failure or refractory
Definitive treatment targets the underlying cause (parathyroidectomy for PHPT, cancer-directed therapy, drug cessation, etc.).
Hypertension - Related Articles
- How to Disable Voice Prompts on Your Zeri Blood Pressure Monitor
- Why Left Ventricular Pressure Far Exceeds Right: The Physics of Two Circulations
- What Happens If All Capillaries Open at Once? A Hemodynamic Catastrophe
- Normal Blood Pressure and Pulse for a 57‑Year‑Old Woman
- Understanding and Managing High Blood Pressure: A Comprehensive Guide
- Scalp Pressure Points: 10 Key Locations for Relief, Relaxation & Circulation
- Understanding Blood Pressure Spikes: Mechanisms, Triggers, and Clinical Management
